The burden of cardiovascular disease morbidity and mortality among women with type 2 diabetes mellitus remains high. despite the improvement in therapeutic management over the recent years. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors have revolutionized treatment of cardiovascular disease in subjects with diabetes. However. https://leoners.shop/product-category/pedestal/